We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Assesses Women's Fertility

By Labmedica staff writers
Posted on 20 May 2008
A simple blood test allows women to assess their supply of eggs and the time of their "biological clock.” The fertility test was launched in Florida (USA), and will help women determine what they must do to increase their chances of having a biologic child.

Called PlanAhead, the innovative blood test provides a much more convenient, accurate, and less costly method of assessing a woman's supply of eggs, by combining several factors such as the measurement of ovary-related hormones anti-Müllerian hormone (AMH), inhibin B, and follicle-stimulating hormone (FSH).

The window of opportunity for a woman to conceive naturally depends upon an adequate supply of eggs, which declines with age making it a critical factor in the fertility process. More...
PlanAhead enables women to compare their own supply of eggs with the normal expected range for women of their age and provides valuable directional information by helping them make decisions that are more informed about when to have a child.

The PlanAhead test co-developer Repromedix Corp. (Woburn, MA, USA) selected South Florida Institute for Reproductive Medicine (SFIRM; Miami, FL, USA) to be one of a select number of in vitro fertilization (IVF) centers around the United States to debut the test. Repromedix will expand the test launch to major markets across the country throughout 2008.

"The PlanAhead test represents an extraordinary advance in fertility diagnostics compared to what has previously been available to the general population,” explained Dr. Benjamin Leader, chief medical officer of Repromedix Corp., the nation's leading diagnostic laboratory for fertility testing. "Many fertility experts have long viewed the gold standard of egg supply measurement to be the number of eggs obtained through egg retrieval; an expensive procedure usually reserved for specialty fertility clinics involving hormone injections and minimally invasive procedures. PlanAhead offers similar information to the general public via a simple blood test,” he added.


Related Links:
Repromedix Corp
South Florida Institute for Reproductive Medicine

Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.